Major hyperghrelinemia in advanced well-differentiated neuroendocrine carcinomas: Report of three cases

European Journal of Endocrinology

Volumn 161, Issue 4, 2009, Pages 639-645

  Walter, Thomas ^a,b,c   Chardon, Laurence ^a,b,c   Hervieu, Valérie ^a,b,c   Cohen, Richard ^a,c   Chayvialle, Jean Alain ^a,b,c   Scoazec, Jean Yves ^a,b,c   Lombard Bohas, Catherine ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CHROMOGRANIN A; EVEROLIMUS; GASTRIN; GHRELIN; PROTON PUMP INHIBITOR; SEROTONIN; SOMATOSTATIN; SYNAPTOPHYSIN; HORMONE;

ADULT; ANOREXIA; ARTICLE; BIOCHEMISTRY; BODY MASS; CANCER CLASSIFICATION; CANCER STAGING; CASE REPORT; CLINICAL ASSESSMENT; ENDOCRINE TUMOR; FEMALE; GALLBLADDER TUMOR; GASTRINOMA; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE DEFICIENCY; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGHRELINEMIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER METASTASIS; MALE; MORTALITY; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; PRIORITY JOURNAL; RECTUM TUMOR; APPETITE; BIOSYNTHESIS; BLOOD; FATALITY; METASTASIS; MIDDLE AGED; PATHOLOGY;

ADULT; APPETITE; BODY MASS INDEX; FATAL OUTCOME; FEMALE; GALLBLADDER NEOPLASMS; GHRELIN; HORMONES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; RECTAL NEOPLASMS;

EID: 70349758943     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0073     Document Type: Article

References (30)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H & Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999 402 656-660. (Pubitemid 129516334)
2. Leontiou CA, Franchi G & Korbonits M. Ghrelin in neuroendocrine organs and tumours. Pituitary 2007 10 213-225.
3. Rindi G, Torsello A, Locatelli V & Solcia E. Ghrelin expression and actions: a novel peptide for an old cell type of the diffuse endocrine system. Experimental Biology and Medicine 2004 229 1007-1016. (Pubitemid 39431080)
4. Inhoff T, Monnikes H, Noetzel S, Stengel A, Goebel M, Dinh QT, Riedl A, Bannert N, Wisser AS, Wiedenmann B, Klapp BF, Tache Y & Kobelt P. Desacyl ghrelin inhibits the orexigenic effect of peripherally injected ghrelin in rats. Peptides 2008 29 2159-2168. (Pubitemid 50320433)
5. Tsolakis AV, Stridsberg M, Grimelius L, Portela-Gomes GM, Falkmer SE, Waldum HL & Janson ET. Ghrelin immunoreactive cells in gastric endocrine tumors and their relation to plasma ghrelin concentration. Journal of Clinical Gastroenterology 2008 42 381-388.
6. Rindi G, Savio A, Torsello A, Zoli M, Locatelli V, Cocchi D, Paolotti D & Solcia E. Ghrelin expression in gut endocrine growths. Histochemistry and Cell Biology 2002 117 521-525. (Pubitemid 34666955)
7. Volante M, Allia E, Gugliotta P, Funaro A, Broglio F, Deghenghi R, Muccioli G, Ghigo E & Papotti M. Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors. Journal of Clinical Endocrinology and Metabolism 2002 87 1300-1308. (Pubitemid 36121102)
8. Volante M, Allia E, Fulcheri E, Cassoni P, Ghigo E, Muccioli G & Papotti M. Ghrelin in fetal thyroid and follicular tumors and cell lines: expression and effects on tumor growth. American Journal of Pathology 2003 162 645-654. (Pubitemid 36267871)
9. Raghay K, Garcia-Caballero T, Nogueiras R, Morel G, Beiras A, Dieguez C & Gallego R. Ghrelin loc alization in rat and human thyroid and parathyroid glands and tumours. Histochemistry and Cell Biology 2006 125 239-246. (Pubitemid 43228197)
10. Ekeblad S, Lejonklou MH, Grimfjard P, Johansson T, Eriksson B, Grimelius L, Stridsberg M, Stalberg P & Skogseid B. Co-expression of ghrelin and its receptor in pancreatic endocrine tumours. Clinical Endocrinology 2007 66 115-122. (Pubitemid 44952503)
11. Wasko R, Jaskula M, Kotwicka M, Andrusiewicz M, Jankowska A, Liebert W & Sowinski J. The expression of ghrelin in somatotroph and other types of pituitary adenomas. Neuro Endocrinology Letters 2008 29 929-938.
12. Corbetta S, Peracchi M, Cappiello V, Lania A, Lauri E, Vago L, Beck-Peccoz P & Spada A. Circulating ghrelin levels in patients with pancreatic and gastrointestinal neuroendocrine tumors: identification of one pancreatic ghrelinoma. Journal of Clinical Endocrinology and Metabolism 2003 88 3117-3120. (Pubitemid 36877481)
13. Wang HS, Oh DS, Ohning GV & Pisegna JR. Elevated serum ghrelin exerts an orexigenic effect that may maintain body mass index in patients with metastatic neuroendocrine tumors. Journal of Molecular Neuroscience 2007 33 225-231.
14. Tsolakis AV, Portela-Gomes GM, Stridsberg M, Grimelius L, Sundin A, Eriksson BK, Oberg KE & Janson ET. Malignant gastric ghrelinoma with hyperghrelinemia. Journal of Clinical Endocrinology and Metabolism 2004 89 3739-3744.
15. Solcia E, Klöppel G & Sobin L 2000 Histological Typing of Endocrine Tumours. WHO International Histological Classification of Tumours, edn 2. New York: Springer Verlag, Berlin, Heidelberg New York.
16. Rindi G, Kloppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, Erikssson B, Falchetti A, Falconi M, Komminoth P, Korner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A, Scoazec JY & Wiedenmann B. TNM staging of foregut neuroendocrine tumors: a consensus proposal including a grading system. Virchows Archiv 2006 449 395-401.
17. Rindi G, Kloppel G, Couvelard A, Komminoth P, Korner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A, Scoazec JY & Wiedenmann B. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Archiv 2007 451 757-762. (Pubitemid 47497934)
18. Gauna C, Meyler FM, Janssen JA, Delhanty PJ, Abribat T, van Koetsveld P, Hofland LJ, Broglio F, Ghigo E & van der Lely AJ. Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. Journal of Clinical Endocrinology and Metabolism 2004 89 5035-5042. (Pubitemid 39391445)
19. Broglio F, Gottero C, Prodam F, Gauna C, Muccioli G, Papotti M, Abribat T, Van Der Lely AJ & Ghigo E. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. Journal of Clinical Endocrinology and Metabolism 2004 89 3062-3065. (Pubitemid 38766409)
20. Gauna C, Delhanty PJ, Hofland LJ, Janssen JA, Broglio F, Ross RJ, Ghigo E & van der Lely AJ. Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes. Journal of Clinical Endocrinology and Metabolism 2005 90 1055-1060. (Pubitemid 40279233)
21. Gauna C, Delhanty PJ, van Aken MO, Janssen JA, Themmen AP, Hofland LJ, Culler M, Broglio F, Ghigo E & van der Lely AJ. Unacylated ghrelin is active on the INS-1E rat insulinoma cell line independently of the growth hormone secretagogue receptor type 1a and the corticotropin releasing factor 2 receptor. Molecular and Cellular Endocrinology 2006 251 103-111. (Pubitemid 43728835)
22. Sakata I, Yang J, Lee C, Osborne-Lawrence S, Rovinsky S, Elmquist JK & Zigman J. Co-Localization of ghrelin O-acyltransferase (GOAT) and ghrelin in gastric mucosal cells. American Journal of Physiology. Endocrinology and Metabolism 2009 297 E134-E141.
23. Govoni N, De Iasio R, Cocco C, Parmeggiani A, Galeati G, Pagotto U, Brancia C, Spinaci M, Tamanini C, Pasquali R, Ferri GL & Seren E. Gastric immunolocalization and plasma profiles of acyl-ghrelin in fasted and fasted-refed prepuberal gilts. Journal of Endocrinology 2005 186 505-513. (Pubitemid 41404069)
24. Papotti M, Cassoni P, Volante M, Deghenghi R, Muccioli G & Ghigo E. Ghrelin-producing endocrine tumors of the stomach and intestine. Journal of Clinical Endocrinology and Metabolism 2001 86 5052-5059. (Pubitemid 33020563)
25. Broglio F, van Koetsveld P, Benso A, Gottero C, Prodam F, Papotti M, Muccioli G, Gauna C, Hofland L, Deghenghi R, Arvat E, Van Der Lely AJ & Ghigo E. Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans. Journal of Clinical Endocrinology and Metabolism 2002 87 4829-4832. (Pubitemid 35247084)
26. Shimada M, Date Y, Mondal MS, Toshinai K, Shimbara T, Fukunaga K, Murakami N, Miyazato M, Kangawa K, Yoshimatsu H, Matsuo H & Nakazato M. Somatostatin suppresses ghrelin secretion from the rat stomach. Biochemical and Biophysical Research Communications 2003 302 520-525. (Pubitemid 36279561)
27. Fukuhara S, Suzuki H, Masaoka T, Arakawa M, Hosoda H, Minegishi Y, Kangawa K, Ishii H, Kitajima M & Hibi T. Enhanced ghrelin secretion in rats with cysteamine-induced duodenal ulcers. American Journal of Physiology. Gastrointestinal and Liver Physiology 2005 289 G138-G145. (Pubitemid 40944232)
28. Wang HS, Oh D, Ohning G & Pisegna JR. Increased endogenous ghrelin co-released by neuroendocrine tumors helps to overcome partial ghrelin resistance due to cancer cachexia. Neuropeptides 2006 40 442-443.
29. Iwakura H, Hosoda K, Doi R, Komoto I, Nishimura H, Son C, Fujikura J, Tomita T, Takaya K, Ogawa Y, Hayashi T, Inoue G, Akamizu T, Hosoda H, Kojima M, Kangawa K, Imamura M & Nakao K. Ghrelin expression in islet cell tumors: augmented expression of ghrelin in a case of glucagonoma with multiple endocrine neoplasm type I. Journal of Clinical Endocrinology and Metabolism 2002 87 4885-4888.
30. Arnaldi G, Mancini T, Kola B, Appolloni G, Freddi S, Concettoni C, Bearzi I, Masini A, Boscaro M & Mantero F. Cyclical Cushing's syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors. Journal of Clinical Endocrinology and Metabolism 2003 88 5834-5840. (Pubitemid 38033059)